- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Twenty States Allege ACA Is Unconstitutional in Federal Lawsuit
Twenty states are suing the federal government challenging the constitutionality of the Affordable Care Act (ACA), since the individual mandate was abolished in the tax reform law signed last December by President Donald Trump. The Tax Cuts and Jobs Act eliminated the tax penalty of the ACA, without eliminating the individual mandate itself, according to the lawsuit filed Monday in US District Court in the Northern District of Texas.
Twenty states are suing the federal government challenging the constitutionality of the Affordable Care Act (ACA), since the individual mandate was abolished in the tax reform law signed last December by President Donald Trump.
The Tax Cuts and Jobs Act eliminated the tax penalty of the ACA, without eliminating the individual mandate itself, according to the lawsuit filed Monday in US District Court in the Northern District of Texas.
"Following the enactment of the Tax Cuts and Jobs Act of 2017, the country is left with an individual mandate to buy health insurance that lacks any constitutional basis," the lawsuit stated. "Once the heart of the ACA—the individual mandate—is declared unconstitutional, the remainder of the ACA must also fall."
In the 2012 case against the ACA, a majority of the Supreme Court and the Department of Justice were clear that the tax penalty was an essential component of the law, according to a joint statement from the attorneys general of Texas and Wisconsin, who are leading the suit. They said that when the Supreme Court upheld the ACA, the majority decision stated that without the tax penalty, the mandate that individuals purchase health insurance was an unconstitutional exercise of federal power.
The lawsuit was filed by the attorneys general for the states of Wisconsin, Alabama, Arkansas, Arizona, Florida, Georgia, Indiana, Kansas, Louisiana, Missouri, Nebraska, South Carolina, South Dakota, Tennessee, Utah, West Virginia, Texas, and by the governors of Maine and Mississippi.
California Aims for Equity by Redefining Cancer Care
December 8th 2023Authors highlight key aspects of the California Cancer Care Equity Act, including its focus on Medi-Cal beneficiaries, the requirement for managed care plans to contract with specialized cancer centers, and the definition of complex cancers.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Patients With RA in Remission Withdrawing From TNF Inhibition Show Flare Increases
December 8th 2023New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued a tumor necrosis factor inhibitor (TNFi).
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Research Reveals the Role of Structural Racism in Lung Cancer Risk
December 7th 2023Spanning 22 studies, the analysis illuminated housing disparities, occupational hazards, unequal health care access, economic inequality, and discriminatory industry practices and how they collectively contribute to heightened lung cancer risks.
Read More
Refining Precision Prevention for Benign Breast Disease
December 7th 2023Many questions remain surrounding accurately classifying the risk of developing invasive breast cancer associated with the benign breast disease diagnoses of nonproliferative lesions and proliferative changes without atypia.
Read More
